Captrust Financial Advisors Ligand Pharmaceuticals Inc Transaction History

Captrust Financial Advisors

  • $30.9 Billion
  • Q2 2024

A detailed history of Captrust Financial Advisors transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 12,629 shares of LGND stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,629
Previous 6,717 88.02%
Holding current value
$1.33 Million
Previous $491,000 116.7%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$68.53 - $87.91 $405,149 - $519,723
5,912 Added 88.02%
12,629 $1.06 Million
Q1 2024

May 15, 2024
BUY
$68.64 - $89.2 $27,593 - $35,858
402 Added 6.37%
6,717 $491,000
Q4 2023

Feb 14, 2024
BUY
$49.57 - $72.63 $16,358 - $23,967
330 Added 5.51%
6,315 $451,000
Q3 2023

Nov 14, 2023
BUY
$58.86 - $72.67 $352,277 - $434,929
5,985 New
5,985 $358,000
Q2 2022

Aug 23, 2022
SELL
$74.52 - $117.06 $1,192 - $1,872
-16 Reduced 1.74%
902 $80,000
Q2 2022

Aug 16, 2022
BUY
$74.52 - $117.06 $1,937 - $3,043
26 Added 2.91%
918 $82,000
Q1 2022

May 16, 2022
SELL
$94.99 - $151.56 $42,270 - $67,444
-445 Reduced 33.28%
892 $100,000
Q4 2021

Feb 14, 2022
SELL
$127.69 - $165.85 $21,962 - $28,526
-172 Reduced 11.4%
1,337 $207,000
Q3 2021

Nov 16, 2021
BUY
$102.33 - $144.73 $3,581 - $5,065
35 Added 2.37%
1,509 $210,000
Q2 2021

Aug 16, 2021
SELL
$113.03 - $155.64 $113 - $155
-1 Reduced 0.07%
1,474 $193,000
Q1 2021

May 17, 2021
BUY
$99.52 - $215.83 $135,048 - $292,881
1,357 Added 1150.0%
1,475 $225,000
Q4 2020

Feb 16, 2021
BUY
$80.55 - $106.05 $402 - $530
5 Added 4.42%
118 $12,000
Q3 2020

Nov 17, 2020
SELL
$89.56 - $126.72 $42,093 - $59,558
-470 Reduced 80.62%
113 $11,000
Q2 2020

Aug 14, 2020
SELL
$68.28 - $123.65 $71,625 - $129,708
-1,049 Reduced 64.28%
583 $65,000
Q1 2020

May 15, 2020
BUY
$63.37 - $107.88 $103,419 - $176,060
1,632 New
1,632 $111,000
Q4 2019

Feb 14, 2020
SELL
$96.94 - $113.59 $36,061 - $42,255
-372 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$107.38 - $129.34 $4,295 - $5,173
40 Added 12.05%
372 $42,000
Q1 2019

May 15, 2019
BUY
$105.93 - $142.47 $26,376 - $35,475
249 Added 300.0%
332 $42,000
Q3 2018

Nov 15, 2018
BUY
$211.18 - $274.49 $16,894 - $21,959
80 Added 2666.67%
83 $23,000
Q2 2018

Aug 13, 2018
SELL
$150.77 - $207.98 $904 - $1,247
-6 Reduced 66.67%
3 $1,000
Q1 2018

May 15, 2018
BUY
$138.63 - $182.62 $1,247 - $1,643
9 New
9 $1,000

Others Institutions Holding LGND

# of Institutions
247
Shares Held
17.5M
Call Options Held
61K
Put Options Held
7.8K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.77B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email